TI
TIJ.F Teijin Limited
- Market cap
- EUR 1.95B
- P/E
- -
- P/B
- 0.95x
- ROE
- -24.1%
- Dividend yield
- 2.79%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Mar 2026.
Is TIJ.F undervalued?
Graham numberThe Graham number of Teijin Limited cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Teijin Limited fundamental analysis
No fundamental analysis for Teijin Limited yet.
Teijin Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Teijin Limited
Teijin Limited engages in the fibers, films and sheets, composites, healthcare, and IT businesses in Japan and internationally. The company provides aramid fibers; glass and carbon fibers, composite materials, infusion resins, adhesives, fillers and resin films, and oxidized PAN fibers; polycarbonate sheets and films; high-density polyethylene porous films and materials; and microporous films. It also offers PC resins, polyphenylene sulfide resins, molded parts, flame retard…
Full company profileTeijin Limited financial statements
Teijin Limited annual financial statements (JPY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 741B | 835B | 889B | 854B | 837B | 926B | 1.02T | 960B | 1.01T | 873B |
| Gross Profit | 248B | 269B | 268B | 263B | 255B | 271B | 248B | 211B | 191B | 162B |
| Operating Income | 56.5B | 69.8B | 60.0B | 56.2B | 54.9B | 44.2B | 12.9B | -4.91B | -71.8B | -70.7B |
| EBITDA | - | 116B | 111B | 96.2B | 64.0B | 116B | 80.5B | 91.3B | 4.37B | -64.6B |
| Net Income | 50.1B | 45.6B | 45.1B | 25.3B | -6.66B | 23.2B | -17.7B | -11.7B | 28.3B | -88.0B |
| EPS | 255 | 230 | 235 | 132 | -35 | 121 | -92 | -61 | 147 | -456 |
| Balance Sheet | ||||||||||
| Total Assets | 964B | 986B | 1.02T | 1.00T | 1.04T | 1.21T | 1.24T | 1.25T | 1.06T | 920B |
| Total Liabilities | 612B | 578B | 593B | 593B | 608B | 743B | 791B | 769B | 623B | 551B |
| Shareholders' Equity | 339B | 394B | 412B | 395B | 407B | 440B | 426B | 455B | 431B | 364B |
| Cash & Short-term Investments | 97.8B | 96.4B | 101B | 114B | 170B | 134B | 143B | 126B | 108B | 104B |
| Cash Flow | ||||||||||
| Operating Cash Flow | 79.0B | 80.1B | 80.9B | 94.2B | 108B | 89.7B | 55.1B | 69.5B | 69.8B | - |
| Capital Expenditure | 37.7B | 42.6B | 55.6B | 66.3B | 56.8B | 60.6B | 57.7B | 65.0B | 61.4B | 0.00 |
| Free Cash Flow | - | 34.1B | 22.0B | 23.9B | 46.8B | -111B | -2.65B | 4.41B | 8.42B | - |
| Ratios | ||||||||||
| ROE | 14.8% | 11.6% | 10.9% | 6.4% | -1.6% | 5.3% | -4.2% | -2.6% | 6.6% | -24.1% |
| ROA | 5.2% | 4.6% | 4.4% | 2.5% | -0.6% | 1.9% | -1.4% | -0.9% | 2.7% | -9.6% |
| Net Profit Margin | 6.8% | 5.5% | 5.1% | 3.0% | -0.8% | 2.5% | -1.7% | -1.2% | 2.8% | -10.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Teijin Limited dividends
- Dividend yield
- 2.79%
- Forward dividend
- 0.28 EUR
- Payout ratio
- -
- Ex-dividend date
- Mar 30, 2027
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | - | - | - |
| 2025 | JPY 7.71B | 40 | 27.2% |
| 2024 | JPY 5.29B | 27 | - |
| 2023 | JPY 10.6B | 55 | - |
| 2022 | JPY 10.1B | 52 | 43.5% |
| 2021 | JPY 10.6B | 55 | - |
| 2020 | EUR 13.4B | 70 | 53.2% |
| 2019 | EUR 11.7B | 61 | 25.9% |
| 2018 | EUR 11.8B | 60 | 25.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:5 on Sep 28, 2016.
Who owns Teijin Limited
- Insiders 3.67%
- Institutions 59.40%
- Public & others 36.93%
- Shares outstanding 193M
- Free float 148M
Teijin Limited company profile
- Company name
- Teijin Limited
- Ticker
- TIJ.F
- ISIN
- JP3544000007
- Exchange
- Frankfurt Exchange
- Sector
- Industrials
- Industry
- Industrial Conglomerates
- Employees
- 15,689
- Fiscal year end
- March
- Address
- Kasumigaseki Common Gate West Tower, Tokyo, Japan, 100-8585
- Phone
- 81 3 3506 4529
- Website
- teijin.com
About Teijin Limited
Teijin Limited engages in the fibers, films and sheets, composites, healthcare, and IT businesses in Japan and internationally. The company provides aramid fibers; glass and carbon fibers, composite materials, infusion resins, adhesives, fillers and resin films, and oxidized PAN fibers; polycarbonate sheets and films; high-density polyethylene porous films and materials; and microporous films. It also offers PC resins, polyphenylene sulfide resins, molded parts, flame retardant, and additives; lightweight glass and carbon fiber reinforced composites for automotive applications; and polytrimethylene telephthalate products, artificial leather materials, polyester nanofibers, and recycled polyester fibers. In addition, the company provides pharmaceuticals for bone and joint, respiratory, cardiovascular and metabolic, and other diseases; home oxygen therapy, non-invasive positive pressure ventilation, continuous positive airway pressure, respiratory support, and sleep disordered breathing related devices, as well as sonic accelerated fracture healing system and community-based integrated care system businesses. Further, the company provides implantable medical devices and regenerative medical products. Additionally, it develops and implements engineering solutions for various issues, such as environmental pollution, energy supply stability, and aging-related workforce population decline. Teijin Limited was incorporated in 1918 and is headquartered in Tokyo, Japan.
Teijin Limited management
10- Mr. Akimoto UchikawaPresident, CEO & Representative Director · born 1966
- Mr. Yuji NakaharaCTO, Group President of Specialty Materials, Executive Officer & Director · born 1969
- Mr. Masanori ShimaiCorporate Officer & Chief Financial Officer · born 1964
- Mr. Fumiaki SakuraiGroup Executive Officer & Chief Human Resources Officer
- Mr. Hiroshi Uno D.V.M., Ph.D.Senior Exec.Officer, GM & President of Healthcare Business Group
- Tsunehiro OgawaChief Officer of Special Project, Senior Corporate Project Officer & Teijin Group Exec. Officer
- Noriko HidakaHead of Diversity Promotion Office
- Junji KitahamaGroup Corp. Officer, President of Elec. & Energy and GM, Resin & Plastic Processing Business Unit
- Mr. Yukihiro FunyuCorporate Officer & Chief Digital Officer
- Ichiro KitanoCorporate Officer and Chief Production, Engineering & Procurement Officer